Results 201 to 210 of about 9,310,159 (342)
Validation of immunochromatographic test in broth-enriched rectal swab specimens. [PDF]
Bezerra CLPAM+10 more
europepmc +1 more source
What's New? Data from randomized controlled trials (RCTs) forms a foundation for rectal cancer treatment guidelines. The reliability of such data is therefore essential for evidence‐based clinical decision‐making. This study assessed the robustness of RCTs cited in the latest National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer ...
Nir Horesh+8 more
wiley +1 more source
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li+7 more
wiley +1 more source
Impact of doxycycline pre-exposure prophylaxis (doxyPrEP) for sexually transmitted infections on the microbiome of men who have sex with men on HIV PrEP. [PDF]
Knodel S+12 more
europepmc +1 more source
What's New? Multiple genetic polymorphisms characteristic of type 2 diabetes (T2D) have been associated with unfavorable prognostic outcomes in individuals with both T2D and metastatic colorectal cancer. This study evaluated the impact of T2D genetic polymorphisms on metastatic colon cancer prognosis in a cohort of non‐diabetic patients.
Raffaella Ruggiero+11 more
wiley +1 more source
Surveillance of Multidrug-Resistant Organisms and Trends in Antimicrobial Susceptibility in Chronically Hospitalized Pediatric Patients. [PDF]
Cho YK, Kim YJ, Park SY, Kang HM.
europepmc +1 more source
What's New? Platinum‐based chemotherapy is the first‐line treatment for unresectable gastrointestinal neuroendocrine carcinoma (NEC). Which treatments are most effective following platinum‐based regimens remains unclear. In this study, the authors compared clinical outcomes between NEC patients who received second‐ or later‐line treatments either with ...
Yuki Matsubara+29 more
wiley +1 more source